A Study of TAK-861 in People With Narcolepsy Type 1

Clinical trial NCT06505031 · COMPLETED

Trial details

NCT number: NCT06505031
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Narcolepsy Type 1

Start date: 2024-10-08
Primary completion: 2025-06-04
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.